These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26109723)

  • 21. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
    Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
    Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription.
    Kusano S; Eizuru Y
    Biochem Biophys Res Commun; 2010 Jun; 396(3):608-13. PubMed ID: 20417616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.
    Fujimuro M; Hayward SD
    J Mol Med (Berl); 2004 Apr; 82(4):223-31. PubMed ID: 14991150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
    Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
    Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
    J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
    Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
    Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation.
    Cai Q; Xiao B; Si H; Cervini A; Gao J; Lu J; Upadhyay SK; Verma SC; Robertson ES
    PLoS Pathog; 2012; 8(3):e1002566. PubMed ID: 22396649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.
    Petre CE; Sin SH; Dittmer DP
    J Virol; 2007 Feb; 81(4):1912-22. PubMed ID: 17121789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.
    Chen W; Hilton IB; Staudt MR; Burd CE; Dittmer DP
    J Virol; 2010 Apr; 84(8):3898-908. PubMed ID: 20130056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 inhibition by the LANA protein of KSHV protects against cell death.
    Friborg J; Kong W; Hottiger MO; Nabel GJ
    Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
    Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
    Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
    Lu M; Breyssens H; Salter V; Zhong S; Hu Y; Baer C; Ratnayaka I; Sullivan A; Brown NR; Endicott J; Knapp S; Kessler BM; Middleton MR; Siebold C; Jones EY; Sviderskaya EV; Cebon J; John T; Caballero OL; Goding CR; Lu X
    Cancer Cell; 2013 May; 23(5):618-33. PubMed ID: 23623661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
    Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
    J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
    Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
    J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta.
    Hagen T
    J Virol; 2009 Jun; 83(12):6312-7. PubMed ID: 19321622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDK9 inhibitors reactivate p53 by downregulating iASPP.
    Wu J; Liang Y; Tan Y; Tang Y; Song H; Wang Z; Li Y; Lu M
    Cell Signal; 2020 Mar; 67():109508. PubMed ID: 31866490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.
    Kaul R; Verma SC; Robertson ES
    Virology; 2007 Aug; 364(2):317-29. PubMed ID: 17434559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
    Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.